271 related articles for article (PubMed ID: 1800310)
1. Population dynamics of natural killer cells in the spleen and bone marrow of normal and leukemic mice during in vivo exposure to interleukin-2.
Christopher FL; Dussault I; Miller SC
Immunobiology; 1991 Dec; 184(1):37-52. PubMed ID: 1800310
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of natural killer cell numbers but not function in leukemic infant mice: a system primed in infancy allows survival in adulthood.
Dussault I; Miller SC
Nat Immun; 1993; 12(2):66-78. PubMed ID: 8318817
[TBL] [Abstract][Full Text] [Related]
3. Population dynamics of natural killer cells and T lymphocytes in murine spleen and bone marrow during the development of erythroleukemia: the effect of indomethacin.
Miller SC; Christopher FL; Dussault I
Nat Immun; 1992; 11(2):78-91. PubMed ID: 1498521
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of immunotherapy in aged leukemic mice.
Dussault I; Miller SC
Gerontology; 1995; 41(4):195-204. PubMed ID: 7557496
[TBL] [Abstract][Full Text] [Related]
5. Effect on leukemia cell numbers of in vivo administration of immunotherapeutic agents is age-dependent.
Dussault I; Miller SC
Oncology; 1996; 53(3):241-6. PubMed ID: 8643228
[TBL] [Abstract][Full Text] [Related]
6. Strain differences in natural killer cell-mediated immunity among mice: a possible mechanism for the low natural killer cell activity of A/J mice.
Whyte AL; Miller SC
Immunobiology; 1998 Jul; 199(1):23-38. PubMed ID: 9717665
[TBL] [Abstract][Full Text] [Related]
7. Generation of cytotoxic cells from murine bone marrow by human recombinant IL 2.
Koo GC; Manyak CL
J Immunol; 1986 Sep; 137(6):1751-6. PubMed ID: 2427580
[TBL] [Abstract][Full Text] [Related]
8. Lymphokine-activated killer cell plus recombinant interleukin-2 therapy of erythroleukemia in mice.
Johnson CS; Thurlow SM; Furmanski P
Leukemia; 1989 Feb; 3(2):91-6. PubMed ID: 2783472
[TBL] [Abstract][Full Text] [Related]
9. Generation of natural killer cells from long-term cultures of mouse bone marrow.
Vecchini F; Delfino D; Patrene KD; DeLeo A; Lu L; Herberman RB; Boggs SS
Nat Immun; 1993; 12(1):1-16. PubMed ID: 8431659
[TBL] [Abstract][Full Text] [Related]
10. Echinacea purpurea and melatonin augment natural-killer cells in leukemic mice and prolong life span.
Currier NL; Miller SC
J Altern Complement Med; 2001 Jun; 7(3):241-51. PubMed ID: 11439845
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human interleukin-1 alpha: a potent bio-immunomodifier in vivo in immunosuppressed mice induced by cyclophosphamide, retroviral infection and surgical stress.
Shen RN; Wu B; Lu L; Kaiser HE; Broxmeyer HE
In Vivo; 1994; 8(1):59-63. PubMed ID: 8054512
[TBL] [Abstract][Full Text] [Related]
12. Decline in natural killer cell-mediated immunosurveillance in aging mice--a consequence of reduced cell production and tumor binding capacity.
Dussault I; Miller SC
Mech Ageing Dev; 1994 Aug; 75(2):115-29. PubMed ID: 7823634
[TBL] [Abstract][Full Text] [Related]
13. Effects of a low-pathogen environment on natural killer cells of normal and B lymphocyte-deficient mice.
Christopher FL; Miller SC
Nat Immun Cell Growth Regul; 1991; 10(4):216-25. PubMed ID: 1832742
[TBL] [Abstract][Full Text] [Related]
14. The in vivo effects of steel factor on natural killer lineage cells in murine spleen and bone marrow.
Miller SC; Fleming WH; Zsebo KM; Weissman IL
Nat Immun; 1993; 12(6):293-301. PubMed ID: 7505667
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2.
Hornung RL; Back TC; Zaharko DS; Urba WJ; Longo DL; Wiltrout RH
J Immunol; 1988 Nov; 141(10):3671-9. PubMed ID: 2460546
[TBL] [Abstract][Full Text] [Related]
16. Role of asialo-GM1-positive lymphoid cells in mediating the toxic effects of recombinant IL-2 in mice.
Gately MK; Anderson TD; Hayes TJ
J Immunol; 1988 Jul; 141(1):189-200. PubMed ID: 3259967
[TBL] [Abstract][Full Text] [Related]
17. Effects of cancer immunotherapy with indomethacin and interleukin-2 on murine hemopoietic stem cells.
Saarloos MN; Khoo NK; Lala PK
Cancer Res; 1992 Dec; 52(23):6452-62. PubMed ID: 1423293
[TBL] [Abstract][Full Text] [Related]
18. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
Mulé JJ; Krosnick JA; Rosenberg SA
J Immunol; 1989 Jan; 142(2):726-33. PubMed ID: 2783444
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of natural killer cell-mediated lysis of tumor cells by normal and regenerating bone marrow.
Miller SC; Galley D; Nguyen DM
Immunobiology; 1988 Apr; 177(1):82-90. PubMed ID: 3384448
[TBL] [Abstract][Full Text] [Related]
20. Altered production and renewal of natural killer cells in B-lymphocyte-deficient CBA/N mice.
Miller SC; Christopher FL
Nat Immun Cell Growth Regul; 1989; 8(5):245-54. PubMed ID: 2594018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
